Dark Forest Capital Management LP Buys Shares of 7,439 Maximus, Inc. (NYSE:MMS)

Dark Forest Capital Management LP purchased a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 7,439 shares of the health services provider's stock, valued at approximately $555,000.

Several other hedge funds also recently added to or reduced their stakes in MMS. UMB Bank n.a. raised its stake in Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after acquiring an additional 158 shares during the last quarter. Eastern Bank acquired a new stake in shares of Maximus in the fourth quarter valued at approximately $29,000. V Square Quantitative Management LLC raised its position in shares of Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares during the last quarter. R Squared Ltd purchased a new stake in shares of Maximus in the fourth quarter valued at $54,000. Finally, IFP Advisors Inc lifted its holdings in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after purchasing an additional 302 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Maximus Stock Down 1.1 %

Shares of MMS stock traded down $0.77 on Thursday, hitting $66.19. The stock had a trading volume of 152,192 shares, compared to its average volume of 554,381. The stock's 50 day moving average is $67.66 and its 200-day moving average is $74.14. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The firm has a market capitalization of $3.75 billion, a price-to-earnings ratio of 14.23 and a beta of 0.68. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.81%. Maximus's dividend payout ratio (DPR) is 25.81%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on MMS. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a research note on Thursday, January 2nd. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.